Laboratory Corporation of America(R) Holdings Announces 2007 Third Quarter Results

Third Quarter Net Sales Growth of 12.2% Drives EPS Growth Before Charges of 27.4% BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 25, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and nine months ended September 30, 2007.

Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics

Collaboration to Explore Clinical Uses of Personal Genetics and Tamoxifen FRANKLIN LAKES, N.J. & BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 22, 2007--Medco Health Solutions Inc. (NYSE:MHS) and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced a strategic research

Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 3, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be

LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C.--(BUSINESS WIRE)--Sept. 12, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that for the period of September 12, 2007 to March 11, 2008, its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon

LabCorp Is Scheduled to Present at the Bear Stearns 2007 Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Sept. 7, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T.

Conversion Right Triggered for Labcorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jul 24, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be

Laboratory Corporation of America(R) Holdings Announces 2007 Second Quarter Results

Second Quarter Net Sales Growth of 15.4% Drives EPS Increase of 20.7% BURLINGTON, N.C., July 24 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and six months ended June 30, 2007.

LabCorp is Scheduled to Present at the Jefferies 2007 Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--June 25, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T. Smith, Executive Vice President, Corporate Affairs, are

Laboratory Corporation of America(R) Holdings Agrees to Acquire DSI Laboratories from NCH Healthcare System

NAPLES, Fla.--(BUSINESS WIRE)--June 18, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE-LH), an S&P 500 company and one of the world's premier clinical laboratories, has agreed to acquire DSI Laboratories, Inc., a full-service medical reference and toxicology laboratory

LabCorp Announces Contract Extension with CIGNA HealthCare

BURLINGTON, N.C., Jun 06, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that it has executed a multi-year clinical laboratory services contract renewal with CIGNA HealthCare. LabCorp will continue to be a contracted laboratory provider